Literature DB >> 1139452

The influence of prolonged hyper- and hypothyroid states on the noradrenaline content of rat tissues and on the accumulation and efflux rates of tritiated noradrenaline.

T Tu, C W Nash.   

Abstract

The influence of chronic hyper- and hypothyroidism on the uptake and retention of tritiated noradrenaline ([3-H]NA) and on the endogenous noradrenaline (NA) content of various adrenergically innervated tissues was studied in thyroidectomized and sham-operated euthyroid rats. Half of the thyroidectomized rats were treated daily with thyroxine (25 mug/kg) for 3 or 12 weeks to simulate a condition of chronic hyperthyroidism, while the other half was left untreated to form a hypothyroid group. The body weight and the heart rate of each rat were measured at the end of each experiment, and in addition, at the end of the 3 week experiment, the oxygen consumption and the plasma thyroxine levels were measured to confirm the thyroid state of the animals. At the end of both experiments, each animal was given an intravenous injection of [3-H]NA and the [3-H]NA and the total endogenous NA content of the heart and various other adrenergically innervated tissues were measured on a timed schedule, to compare the initial accumulations and the rates of efflux of [3-H]NA under different thyroid states. Although the hyperthyroid rats had higher heart rates and heart weights, they were not significantly different from the euthyroid controls with respect to their body weights, tissue NA content, or accumulation and efflux rates of [3-H]NA. In contrast, the hypothyroid rats showed significantly lower heart and other tissue weights, but higher tissue concentrations of NA and rates of efflux of [3-H]NA than the euthyroid group. In the hypothyroid state, the NA turnover appeared to be increased as the [3-H]NA efflux rate was increased from the hearts and adrenal glands. There were no significant differences between the results of the 3 week and the 12 week experiments and no evidence that prolongation of the hyperthyroid state gave different results from those found by other workers who used much shorter treatment periods and larger doses of thyroxine to develop hyperthyroidism.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1139452     DOI: 10.1139/y75-009

Source DB:  PubMed          Journal:  Can J Physiol Pharmacol        ISSN: 0008-4212            Impact factor:   2.273


  6 in total

1.  The effects of thyroxine treatment of rats on neuronal and extraneuronal uptake and metabolism of catecholamines in the heart.

Authors:  L J Bryan; S R O'Donnell; A M Williams
Journal:  Br J Pharmacol       Date:  1986-02       Impact factor: 8.739

2.  Functional state of the autonomic nervous system in patients with euthyroid and thyrotoxic goiter.

Authors:  V N Aleksandrov; S Z Kletskin; I A Shukhgalter; I V Akatov; T I Nikitina; B I Gorbatyi
Journal:  Neurosci Behav Physiol       Date:  1986 Nov-Dec

3.  The paradoxical lean phenotype of hypothyroid mice is marked by increased adaptive thermogenesis in the skeletal muscle.

Authors:  Rachel R Kaspari; Andrea Reyna-Neyra; Lara Jung; Alejandra Paola Torres-Manzo; Sandro M Hirabara; Nancy Carrasco
Journal:  Proc Natl Acad Sci U S A       Date:  2020-08-21       Impact factor: 11.205

4.  Thyroid hormone modulates inotropic responses, alpha-adrenoceptor density and catecholamine concentrations in the rat heart.

Authors:  J Zwaveling; H D Batink; J de Jong; E A Winkler Prins; M Pfaffendorf; P A van Zwieten
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-12       Impact factor: 3.000

5.  The influence of hormonal and neuronal factors on rat heart adrenoceptors.

Authors:  G Kunos; L Mucci; S O'Regan
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

6.  Disruption of thyroid hormone activation in type 2 deiodinase knockout mice causes obesity with glucose intolerance and liver steatosis only at thermoneutrality.

Authors:  Melany Castillo; Jessica A Hall; Mayrin Correa-Medina; Cintia Ueta; Hye Won Kang; David E Cohen; Antonio C Bianco
Journal:  Diabetes       Date:  2011-02-18       Impact factor: 9.461

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.